| Net Cash Provided by (Used in) Operating Activities |
$6,210 |
USD |
43% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$24,200 |
USD |
124% |
Q4 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$18,000 |
USD |
|
Q4 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
|
Q4 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
223,548,220 |
shares |
|
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
|
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$10 |
USD |
|
Q4 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$467 |
USD |
|
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$193,765 |
USD |
15% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$193,765 |
USD |
15% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
5,000,000 |
shares |
|
Q4 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
30,000,000 |
shares |
|
Q4 2025 |
Q1 2026 |
| Additional Paid in Capital |
$408,436 |
USD |
|
Q4 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
5,000,000 |
shares |
|
Q4 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
FY 2025 |
| Interest Expense |
$81 |
USD |
-100% |
Q4 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
|
Q4 2025 |
Q1 2026 |